title: Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA binding.
abstract: Interferon regulatory factors IRF-3 and IRF-7 are transcription factors essential in the activation of interferon-β (IFN-β) gene in response to viral infections. Although, both proteins recognize the same consensus IRF binding site AANNGAAA, they have distinct DNA binding preferences for sites in vivo. The X-ray structures of IRF-3 and IRF-7 DNA binding domains (DBDs) bound to IFN-β promoter elements revealed flexibility in the loops (L1-L3) and the residues that make contacts with the target sequence. To characterize the conformational changes that occur on DNA binding and how they differ between IRF family members, we have solved the X-ray structures of IRF-3 and IRF-7 DBDs in the absence of DNA. We found that loop L1, carrying the conserved histidine that interacts with the DNA minor groove, is disordered in apo IRF-3 but is ordered in apo IRF-7. This is reflected in differences in DNA binding affinities when the conserved histidine in loop L1 is mutated to alanine in the two proteins. The stability of loop L1 in IRF-7 derives from a unique combination of hydrophobic residues that pack against the protein core. Together, our data show that differences in flexibility of loop L1 are an important determinant of differential IRF-DNA binding.
authors: Department of Structural and Chemical Biology, Mount Sinai School of Medicine, Box 1677, 1425 Madison Avenue, NY 10029, USA.
authors: Pablo
authors: P
authors: De Ioannes
authors: Carlos R
authors: CR
authors: Escalante
authors: Aneel K
authors: AK
authors: Aggarwal
references: Annu Rev Biochem. 1990;59:933-69
references: 2197994
references: EMBO J. 1999 Sep 15;18(18):5028-41
references: 10487755
references: Proc Natl Acad Sci U S A. 1988 Mar;85(5):1447-51
references: 3422743
references: J Interferon Cytokine Res. 2009 Dec;29(12):765-80
references: 19929577
references: J Biol Chem. 2007 Jul 13;282(28):20065-9
references: 17502370
references: Methods Enzymol. 1997;276:307-26
references: 27754618
references: Cell. 2007 Jun 15;129(6):1111-23
references: 17574024
references: J Biol Chem. 1998 Jan 30;273(5):2714-20
references: 9446577
references: Mol Cell Biol. 2000 Sep;20(17):6342-53
references: 10938111
references: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
references: 20124702
references: Biochemistry. 2005 Nov 1;44(43):14202-9
references: 16245936
references: Ann N Y Acad Sci. 2003 Dec;1010:237-48
references: 15033728
references: Annu Rev Immunol. 2001;19:623-55
references: 11244049
references: Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1451-6
references: 11567159
references: Gene. 1999 Sep 3;237(1):1-14
references: 10524230
references: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references: 19461840
references: Nature. 1998 Jan 1;391(6662):103-6
references: 9422515
references: Structure. 1998 Apr 15;6(4):491-500
references: 9562558
references: Mol Cell. 2002 Nov;10(5):1097-105
references: 12453417
references: Joint Bone Spine. 2010 Dec;77(6):525-31
references: 20863736
references: J Mol Med (Berl). 1997 May;75(5):348-59
references: 9181476
references: Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1369-73
references: 1705037
references: EMBO J. 2004 Nov 10;23(22):4384-93
references: 15510218
references: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references: 15299926
references: Cytokine Growth Factor Rev. 1997 Dec;8(4):293-312
references: 9620643
references: Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
references: 9757107
references: Mol Cell. 2007 Jun 8;26(5):703-16
references: 17560375
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references: 15572765